Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
Our top-notch dedicated system is used to design specialised libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes comprehensive molecular simulations of the catalytic and allosteric binding pockets and the ensemble virtual screening accounting for their conformational mobility. In the case of designing modulators, the structural changes induced by reaction intermediates are taken into account to leverage activity and selectivity.
Key features that set our library apart include:
partner
Reaxense
upacc
O75648
UPID:
MTU1_HUMAN
Alternative names:
MTO2 homolog
Alternative UPACC:
O75648; A8K3U7; Q05C99; Q5W9C8; Q66K31; Q6ICC3; Q9NWC1
Background:
Mitochondrial tRNA-specific 2-thiouridylase 1, also known as MTO2 homolog, plays a crucial role in mitochondrial function by catalyzing the 2-thiolation of uridine at the wobble position of mitochondrial tRNA. This enzymatic activity is essential for the formation of 5-taurinomethyl-2-thiouridine at the wobble position, a modification necessary for proper mitochondrial tRNA function and protein synthesis.
Therapeutic significance:
The protein is implicated in diseases such as aminoglycoside-induced deafness and transient infantile liver failure, highlighting its potential as a target for therapeutic intervention. Understanding the role of Mitochondrial tRNA-specific 2-thiouridylase 1 could open doors to potential therapeutic strategies, especially in mitigating the effects of mitochondrial mutations and improving mitochondrial function.